Stay updated on Dupilumab in Pediatric Peanut Allergy Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Pediatric Peanut Allergy Clinical Trial page.

Latest updates to the Dupilumab in Pediatric Peanut Allergy Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA minor site revision update was made, adding Revision: v3.3.4 and removing Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedA new dedicated Locations section has been added with regional site listings (California, Florida, Indiana, Michigan, New York, Ontario, Quebec), and the previous location groupings have been removed.SummaryDifference0.8%

- Check58 days agoChange DetectedPublications section wording updated to indicate that publications are automatically filled from PubMed and may not be about the study. The revision/version label was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check65 days agoChange DetectedDeleted the funding-lapse notice from the page. This change does not affect study data, eligibility criteria, or results.SummaryDifference0.4%

- Check79 days agoChange DetectedCore study information (title, objectives, eligibility criteria, interventions, outcomes, and locations) remains unchanged between the screenshots, with only minor formatting adjustments observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check108 days agoChange DetectedAdditions introduce a government operating-status notice and a version update to v3.2.0; deletions remove the previous v3.1.0 tag. The main impact is informing users about current status and a version change, with no changes to core offers or pricing.SummaryDifference3%

Stay in the know with updates to Dupilumab in Pediatric Peanut Allergy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Pediatric Peanut Allergy Clinical Trial page.